Novavax (NVAX) Market Capitalization (2010 - 2026)
Novavax's Market Capitalization came in at $1.55 billion for Q2 2026, up 52.0% from $1.02 billion a year earlier and up 16.0% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Market Capitalization (2010 - 2026) Analysis & Trends
For FY2025, Novavax's Market Capitalization was $1.09 billion, down 15.3% from FY2024.
- Market Capitalization carries a five-year compound annual growth rate of -29.8% (FY2020 to FY2025).
- Going back by year, Market Capitalization was $1.29 billion in FY2024 (+166.7%), $483.69 million in FY2023 (-45.3%), $884.49 million in FY2022 (-91.8%) and $10.85 billion in FY2021 (+69.1%).
- The Q2 2026 figure represents the highest quarterly Market Capitalization since Q3 2024.
- Year-over-year, Market Capitalization increased in five of the last eight quarters, with growth averaging 42.8%.
- The fastest year-over-year change in Market Capitalization over five years came in Q2 2024 (growth of 188.9%), and the weakest in Q4 2022 (a decline of 91.8%).
- Business Quant data shows NVAX's Market Capitalization at $1.34 billion (Q1 2026), $1.09 billion (Q4 2025) and $1.41 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Novavax | 1.78 Bn | -1.22 Bn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Bn |
| Mar 31, 2026 | 1.34 Bn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 1.41 Bn |
| Jun 30, 2025 | 1.02 Bn |
| Mar 31, 2025 | 1.04 Bn |
| Dec 31, 2024 | 1.29 Bn |
| Sep 30, 2024 | 2.02 Bn |
| Jun 30, 2024 | 2.02 Bn |
| Mar 31, 2024 | 670.98 Mn |
| Dec 31, 2023 | 483.69 Mn |
| Sep 30, 2023 | 859.61 Mn |
| Jun 30, 2023 | 700.71 Mn |
| Mar 31, 2023 | 598.00 Mn |
| Dec 31, 2022 | 884.49 Mn |
| Sep 30, 2022 | 1.43 Bn |
| Jun 30, 2022 | 4.02 Bn |
| Mar 31, 2022 | 5.75 Bn |
| Dec 31, 2021 | 10.85 Bn |
| Sep 30, 2021 | 15.63 Bn |
API Access
Novavax Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();